PacBio (PACB) Q4 Earnings Report Preview: What To Look For
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results tomorrow after market ...
Fierce Biotech4d
DNA sequencing shares slide amid 'headwinds' from Trump's NIH funding cuts
After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...
Trump’s Cuts to Medical Research Are Hurting These Stocks
Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of ...
Bruker price target lowered to $65 from $69 at Barclays
Barclays analyst Luke Sergott lowered the firm’s price target on Bruker to $65 from $69 and keeps an Overweight rating on the shares. The firm ...
Yahoo Finance1d
Illumina, Inc. (ILMN)
Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of California lost 18% and 15%, respectively. We recently published a list of Jim ...
10x Genomics price target lowered to $18 from $19 at Barclays
Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...
Hosted on MSN22d
Life sciences stocks fall on NIH funding concerns
PACB), also known as PacBio, both fell 10%, while Illumina (NASDAQ:ILMN) and Bio-Rad (BIO) shares fell 5% and 4%, respectively. Shares of Qiagen (QGEN) and Bruker (BRKR) slid 3%, with shares of ...
Pacific Biosciences of California, Inc. (PACB) Q4 2024 Earnings Call Transcript
Pacific Biosciences of California, Inc. ( NASDAQ: PACB) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Todd Friedman - Senior Director, Finance and Investor Relations Christian Henry - ...